Application 091617
- Type
- ANDA
- Sponsor
- ALEMBIC PHARMS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM | TABLET;ORAL | 12.5MG;50MG | No | No |
| 002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM | TABLET;ORAL | 12.5MG;100MG | No | No |
| 003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM | TABLET;ORAL | 25MG;100MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | |
| A091617-002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM | 12.5MG;100MG | TABLET / ORAL | AB | 2012-02-17 | |
| A091617-003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM | 25MG;100MG | TABLET / ORAL | AB | 2012-02-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A091617-001 | AB |
| A091617-002 | AB |
| A091617-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091617-002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A091617-003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 25MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091617-002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091617-003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 25MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091617-002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A091617-003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 25MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091617-002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;100MG | TABLET / ORAL | AB | 2012-02-17 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091617-003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 25MG;100MG | TABLET / ORAL | AB | 2012-02-17 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091617-002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;100MG | TABLET / ORAL | AB | 2012-02-17 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091617-003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 25MG;100MG | TABLET / ORAL | AB | 2012-02-17 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091617-002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091617-003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 25MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091617-002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091617-003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 25MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091617-002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091617-003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 25MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091617-002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;100MG | TABLET / ORAL | AB | 2012-02-17 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091617-003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 25MG;100MG | TABLET / ORAL | AB | 2012-02-17 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091617-002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;100MG | TABLET / ORAL | AB | 2012-02-17 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A091617-003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 25MG;100MG | TABLET / ORAL | AB | 2012-02-17 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091617-002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091617-003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 25MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091617-002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091617-003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 25MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091617-002 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091617-003 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 25MG;100MG | TABLET / ORAL | AB | 2012-02-17 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A091617-001 | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | 12.5MG;50MG | TABLET / ORAL | AB | 2012-02-17 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A091617-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A091617-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A091617-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091617-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091617-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A091617-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A091617-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A091617-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A091617-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091617-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091617-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A091617-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091617-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091617-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A091617-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091617-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091617-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A091617-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091617-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091617-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A091617-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091617-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091617-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A091617-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091617-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091617-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A091617-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A091617-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A091617-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A091617-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091617-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091617-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A091617-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091617-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091617-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A091617-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091617-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091617-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A091617-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A091617-001 | AB | 1 | 8072bd15b7f6… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Inc. | acecced9-2a61-435d-b7d4-b151cb7b7e5d | 2025-12-26 | Boxed warning, Warnings, Adverse reactions | 091617 ANDA091617 62332-048 62332-049 62332-050 |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Alembic Pharmaceuticals Limited | bbf7e20d-dfc2-4115-8788-c0cac15a1148 | 2025-09-23 | Boxed warning, Warnings, Adverse reactions | 091617 ANDA091617 46708-450 46708-448 46708-449 |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 5e35e3b9-7d79-b32a-e053-2991aa0ae9c0 | 2025-02-03 | Boxed warning, Warnings, Adverse reactions | 091617 ANDA091617 68071-4159 |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 6dd115b5-9268-4b66-bae8-0aa2605ebbd3 | 2021-01-01 | Boxed warning, Warnings, Adverse reactions | 091617 ANDA091617 63187-394 |
| Losartan Potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Proficient Rx LP | 33710c3c-6f17-457a-8665-04c23bca8b75 | 2019-11-01 | Boxed warning, Warnings, Adverse reactions | 091617 ANDA091617 63187-918 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 46708-448 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-448 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-449 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-449 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-450 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-450 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Limited | ANDA | Current |
| 50090-3135 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | A-S Medication Solutions | ANDA | Current |
| 50090-3135 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | A-S Medication Solutions | ANDA | Current |
| 50090-4274 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | A-S Medication Solutions | ANDA | Current |
| 50090-4274 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | A-S Medication Solutions | ANDA | Current |
| 62332-048 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-048 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-048 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-048 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-048 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-048 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-049 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-049 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-049 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-049 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-049 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-049 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-050 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-050 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-050 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-050 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-050 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-050 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 63187-394 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Proficient Rx LP | ANDA | Current |
| 63187-394 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Proficient Rx LP | ANDA | Current |
| 63187-918 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Proficient Rx LP | ANDA | Current |
| 63187-918 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Proficient Rx LP | ANDA | Current |
| 68071-4159 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4159 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4159 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4187 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4222 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | NuCare Pharmaceutiacals,I | ANDA | Current |
| 68071-4222 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | NuCare Pharmaceutiacals,Inc. | ANDA | Current |
| 68071-4222 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | NuCare Pharmaceutiacals,Inc. | ANDA | Current |
| 68071-4768 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 68071-4768 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | NuCare Pharmaceuticals,Inc. | ANDA | Current |
| 70518-0786 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | REMEDYREPACK INC. | ANDA | Current |
| 70518-0786 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | REMEDYREPACK INC. | ANDA | Current |
| 70518-0786 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | REMEDYREPACK INC. | ANDA | Current |
| 70518-0786 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | REMEDYREPACK INC. | ANDA | Current |
| 70518-1943 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | REMEDYREPACK INC. | ANDA | Current |
| 70518-1943 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | REMEDYREPACK INC. | ANDA | Current |
| 71335-1025 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Bryant Ranch Prepack | ANDA | Current |
| 71335-1025 | Losartan Potassium and Hydrochlorothiazide | Losartan Potassium and Hydrochlorothiazide | Bryant Ranch Prepack | ANDA | Current |